Some members of Congress feel the measure might go too far. Drug companies don't like it, either.
Tuesday, the Senate Finance Committee is scheduled to hold its confirmation hearing for Alex Azar to run the U.S. Department of Health and Human Services. Azar is widely expected to win Senate approval, despite some misgivings over the rise of drug prices while he served as a top executive at drugmaker Eli Lilly. However, it […]